The manuscript, Scale-up of transgenic tobacco cells that express intimin of enterohemorrhagic Escherichia coli O157:H7 as a transitional platform for an oral cattle vaccine, (Ref.: Ms. No. IVPL-D-13-00224R2) which details work 'resurrected' from ~2003-5 including work by Kristin O'Neill (now at Merck for nearly a decade) has finally been accepted! Accepted for publication in In Vitro Cellular and Developmental Biology – Plant as of January 16th, 2015. |
Lab News >
